xposure to air pollution is associated with several significant adverse health outcomes; however, this association is particularly strong for fine particulate matter (PM 2.5 ) and cardiovascular injury. 1 Epidemiological studies have shown that ambient PM 2.5 exposure increases atherogenesis, thrombosis, and the incidence of myocardial infarction, stroke, and sudden cardiac death. [2] [3] [4] Although the mechanisms by which PM 2.5 exposure exacerbates cardiovascular disease and precipitates acute cardiovascular events remain unclear, a common underlying feature that links PM 2.5 exposure to cardiovascular disease seems to be a dysfunctional endothelium. 5, 6 Previous studies have shown that chronic PM 2.5 exposure is associated with decreased endothelial function and hypertension, 7, 8 suggesting that long-term PM 2.5 inhalation might result in endothelial injury and dysregulation of vascular homeostasis; effects that could accelerate cardiovascular disease or trigger adverse cardiovascular events.
Vascular homeostasis and endothelial health are thought to be maintained, in part, by a subpopulation of proangiogenic cells-the endothelial progenitor cells (EPCs) that reside in the bone marrow and circulate in the peripheral blood. 9 Although the precise phenotypic definition of these cells remains controversial, 10 it has been shown that upon hypoxia or vascular injury, EPCs are mobilized from the bone marrow and home to the site of tissue damage. At these sites, EPCs contribute to vasculogenesis or angiogenesis either through terminal differentiation into mature endothelial cells or by paracrine stimulation of wound healing processes. 11 In agreement with a critical role of EPCs in maintaining vascular health, it has been found that circulating EPC levels acutely increase after cardiovascular injuries, such as myocardial infarction, and that chronically suppressed circulating EPC levels are associated with an increase in cardiovascular disease risk and burden. 12, 13 Our previous work has shown that acute PM 2.5 exposure depletes circulating EPCs in humans and mice and that PM 2.5 exposure impairs the VEGF (vascular endothelial growth factor)-mediated mobilization of these cells from the bone marrow of mice. 14, 15 These observations suggest that early PM 2.5 -induced changes in EPCs might precede (and may be causal in) subsequent adverse cardiovascular dysfunction. Nevertheless, the effects of PM 2.5 on EPC function and angiogenic competence have not been studied, and the molecular mechanisms by which PM 2.5 affects EPC number, function, and competence remain unknown.
Thus, in the current study, we assessed whether PM 2.5 exposure affects EPC function in vitro and evaluated the competence of these cells in promoting recovery of hindlimb perfusion after ischemia in vivo. Because increased pulmonary oxidative stress has been suggested to mediate PM 2.5 -induced cardiovascular injury, 1 we also examined whether increasing the pulmonary antioxidant capacity, by overexpressing extracellular superoxide dismutase (ecSOD), could prevent the sequelae of events leading to PM 2.5 -induced EPC dysfunction. We found that PM 2.5 exposure inhibited EPC-mediated recovery after hindlimb ischemia (HLI) and that increasing the antioxidant capacity of the lung prevented this dysfunction. These findings provide new insights into the mechanism by which PM 2.5 exposure contributes to vascular dysfunction that reveals a novel link between pulmonary oxidative stress and impaired wound healing.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Exposure to PM 2.5 Decreases EPC Growth and Tube Formation
Our previous studies have shown that exposure to PM 2.5 depletes circulating EPCs in both humans and mice. 14, 15 To determine whether PM 2.5 exposure is also associated with impairments in EPC function, we examined the growth and tube-forming capacity of these cells after their isolation from mice exposed to concentrated ambient PM 2.5 (CAP). Because of the limited number of circulating EPCs, we used bone marrow-derived EPCs for this functional assessment. As shown before, 14 after 7 to 10 days of culture, these cells exhibited positive staining for the stem cell marker, Sca-1 (stem cells antigen-1), and the endothelial cell marker, Flk-1 (fetal liver kinase-1; vascular endothelial growth factor receptor-2; Figure 1A ), indicating that under the culture conditions used, bone marrow cells proliferate into progenitor cells with endothelial characteristics.
To assess growth, we isolated and cultured EPCs from the bone marrow of mice exposed to CAP or breathing filtered air (control) for 9 days and determined proliferation rates. We found that the doubling rate of cells from CAP-exposed mice was 2.7±1.0-fold greater than that of cells from mice breathing filtered air ( Figure 1B) . However, this slower growth was not because of increased senescence or apoptosis/necrosis because CAP exposure did not increase β-galactosidase + or Annexin V + /7AAD + staining ( Figure 1B ). To gain mechanistic insights into this proliferative defect, we analyzed the expression of genes encoding for cell cycle-and mitosis-associated proteins (Table I in Figure 1B ) indicated that genes that support proliferation and promote cell cycle progression (ie, Stratifin, 14-3-3-σ and Myb, c-myb) [16] [17] [18] [19] were downregulated in EPCs isolated from CAP-exposed mice. In contrast, the antiproliferative genes Gpr132 (G2A) 20, 21 and p16 INK4 (Cdkn2a) 22, 23 and Schlafen1, 24, 25 which are associated with cell cycle arrest and the inhibition of EPC proliferation, were upregulated in EPCs cultured from CAP-exposed mice.
To determine whether CAP exposure affects EPC function in vitro, we performed a tube-forming assay. Although cells from filtered air-breathing mice formed tubes efficiently, EPCs from CAP-exposed mice were less efficient in doing so ( Figure 1C ). Positive calcein-AM staining indicates that EPCs from CAP-exposed mice maintained their viability during this assay. Taken together, these results suggest that PM 2.5 exposure impairs the growth and tube-forming capacity of EPCs. These effects were not because of cell senescence or apoptosis/necrosis and were sustained even after prolonged culture.
Effect of Pulmonary ecSOD on PM 2.5 -Induced EPC Dysfunction and Redox Status
Because the cardiovascular effects of PM 2.5 have been suggested to be because of pulmonary oxidative stress 1 and our previous work showing that pulmonary overexpression of ecSOD prevents PM 2.5 -induced oxidative stress, 26 we examined whether lung-specific ecSOD overexpression would prevent the PM 2.5 -induced impairment in tube formation. For this, we exposed wild-type (WT) and ecSOD-transgenic (ecSOD-Tg) mice to CAP for 9 days. As before, CAP exposure decreased tube formation of bone marrow-derived EPCs isolated from WT mice by ≈60% (24±3 WT-air versus 9±1 WT-CAP; Figure 1D ). In contrast, even though cells from ecSOD-Tg mice seem to have a 25% lower basal tube-forming capacity than EPCs from WT mice (24±3 WT-air versus 18±5 ecSOD-air; Figure 1D ), CAP exposure did not further diminish the number of tubes formed by EPCs from ecSOD-Tg mice. These data suggest that CAPinduced functional defects in bone marrow-derived EPCs are mediated, in part, by pulmonary oxidative stress.
In view of this observation, we next examined whether PM 2.5 -induced pulmonary oxidative stress affects the redox status of EPCs. To examine redox changes, we measured reduced glutathione (GSH) levels in lungs and in circulating and bone marrow-resident EPCs. As shown in Figure 2A , CAP exposure significantly increased the levels of oxidized GSH (GSSG) in the lungs of WT mice but not in ecSODTg mice indicating that the overexpression of ecSOD in the lung epithelium is sufficient to protect against CAP-induced pulmonary oxidative stress. Indeed, CAP exposure significantly decreased the ratio of reduced:oxidized glutathione (GSH:GSSG) by 35±12% ( Figure 2B ) and increased thiobarbituric acid reactive substance (TBARS) levels by 25±8% ( Figure 2C ) in the lungs of WT mice but did not change these outcomes in ecSOD-Tg mice. Although air-exposed ecSODTg mice seem to have basally lower GSH:GSSG ratios and elevated levels of TBARS ( Figure 2B and 2C), these differences were not significant. To measure GSH levels in circulating and bone marrowresident EPCs, we used the fluorescent reporter monochlorobimane in a flow cytometry approach ( Figure 2D through 2F) . We found that the median monochlorobimane fluorescence in circulating and bone marrow-resident Flk-1 + /Sca-1 + cells of CAP-exposed WT mice was significantly lower than that in EPCs of WT mice breathing filtered air ( Figure 2E and 2F) indicating that PM 2.5 exposure depletes GSH in both circulating and bone marrow EPCs. In contrast, no significant CAPinduced changes in monochlorobimane fluorescence were observed in circulating or bone marrow-resident EPCs from the ecSOD-Tg mice indicating that EPCs from ecSOD-Tg mice are protected against CAP-induced redox changes although circulating and bone marrow-resident EPCs from ecSOD-Tg mice show a lower monochlorobimane fluorescence basally.
Taken together, these results suggest that particle inhalation (a pulmonary insult) impacts distal cells, such as circulating and bone marrow-resident EPCs. This is supported by our observation that ecSOD-Tg mice are protected against CAPinduced pulmonary oxidative stress and oxidative alterations in circulating and bone marrow-resident EPCs. + ) staining were quantified (left). Data are presented as mean±SEM normalized to air controls (n=9-11; *P<0.05). The expression of genes coding for cell cycle-and mitosis-associated proteins was examined by gene array (Table I in 
-Induced Changes in EPC Homeostasis Are Prevented by Pulmonary Overexpression of ecSOD
Previously, we reported that PM 2.5 exposure disrupts EPC homeostasis in mice, characterized by the depletion of EPCs in the circulation and a reciprocal increase in the bone marrow. 14, 27 To determine whether these changes are because of pulmonary oxidative stress, we measured EPC levels in WT and ecSOD-Tg mice inhaling CAP or filtered air for 9 days ( Figure 3 ). Consistent with our previous observations, 14, 27 we found that CAP exposure decreased the number of circulating Flk-1 + /Sca-1 + cells in WT mice ( Figure 3A) . However, CAP exposure did not induce the depletion of circulating EPCs in ecSOD-Tg mice. Similarly, even though CAP exposure led to an accumulation of EPCs in the bone marrow of WT mice, no such CAP-induced increase of EPCs was observed in the bone marrow of the ecSOD-Tg mice ( Figure 3B ). These observations suggest that PM 2.5 inhalation leads to pulmonary oxidative stress that induces changes in EPC homeostasis possibly by interfering with EPC trafficking from the bone marrow into the peripheral blood as the number of circulating EPCs decrease, whereas the levels of bone marrow cells increase.
Although circulating EPC levels were similar in airor CAP-inhaling ecSOD-Tg mice and air-breathing WT mice ( Figure 3A) , the levels of bone marrow-resident EPCs were similar in CAP-exposed ecSOD-Tg and WT mice ( Figure 3A) . Thus, even though overexpression of pulmonary ecSOD prevents the CAP-induced accumulation of EPCs in the bone marrow, the mechanism by which EPC homeostasis is maintained in ecSOD-Tg mice seems to be more complex. We found that CAP exposure increased plasma VEGF and SCF levels in ecSOD-Tg (Table) , and because stimulation of the bone marrow (eg, by growth factors or cytokines/chemokines) induces not only the egress of EPCs but also promotes their proliferation and maturation, 28 it appears that pulmonary ecSOD overexpression, especially under CAP exposure, stimulates EPC proliferation and maturation in the bone marrow.
Pulmonary Overexpression of ecSOD Prevents PM 2.5 -Induced VEGF Resistance
Our previous study showed that PM 2.5 exposure blocked the VEGF-mediated mobilization of EPCs, which was accompanied by impaired vascular VEGF signaling.
14 Moreover, our recent work has shown that PM 2.5 -induced pulmonary oxidative stress contributes to the induction of aortic inflammation and insulin resistance. 26 Hence, we next tested whether pulmonary ecSOD overexpression protected from CAP-induced aortic VEGF resistance. As reported previously, 14 we found that CAP exposure blunted VEGF-stimulated Akt phosphorylation in aortas of WT mice ( Figure 4A ). In contrast, VEGF-stimulated Akt phosphorylation was preserved in CAPexposed ecSOD-Tg mice. Moreover, CAP exposure decreased plasma nitrite levels in WT mice but not in ecSOD-Tg mice ( Figure 4B ). These results suggest that pulmonary ecSOD overexpression protected against CAP-induced VEGF resistance and the depletion of plasma NO and thus may enhance NO bioavailability in CAP-exposed animals. Consistent with this observation, CAP exposure also increased plasma VEGF and SCF levels in ecSOD-Tg mice (Table) , suggesting that pulmonary overexpression of ecSOD preserves proangiogenic responses.
Exposure to PM 2.5 Impairs EPC-Mediated Angiogenesis and Vascular Repair
Because EPCs from CAP-exposed mice showed impaired proliferative and tube-forming capacities, we hypothesized that CAP exposure might interfere with the in vivo vascular repair competency of these cells. Previous work has shown that transplantation of exogenous EPCs into ischemic tissue promotes postischemic recovery and angiogenesis. 29 Hence, we tested whether CAP exposure affects this reparative capacity of EPCs. To do this, cultured bone marrow EPCs isolated from mice exposed to CAP or breathing filtered air for 9 or 30 days were injected into the skeletal muscle of unexposed mice immediately after ligation and transection of the femoral artery and vein. We then followed the recovery of vascular perfusion after this HLI using laser Doppler perfusion imaging ( Figure 5A ). Injection of EPCs derived from filtered air-breathing mice accelerated recovery after HLI when compared with responses in mice receiving only equivalent volumes of saline ( Figure 5B) , consistent with the finding that exogenous EPCs promote recovery from HLI. 29 However, although recovery of vascular perfusion was 53.5±5.2% (of nonischemic hindlimb) in animals receiving EPCs from filtered air-breathing mice, recovery was only 37.8±4.8% or 34.3±1.4% in animals receiving EPCs from mice exposed to CAP for 9 or 30 days, respectively ( Figure 5B ).
To further examine the effects of EPC injection on tissue repair, hindlimb muscles were stained with isolectin and Sirius red as markers of endothelium (capillaries) and collagen (fibrosis), respectively. The immunohistological assessment showed that muscles of animals receiving EPCs from CAP-exposed mice had only 65.8±8.0% of the isolectin (endothelial cell) content ( Figure 5C ) and only 55.6±13.6% of the collagen content ( Figure 5D ) of the muscles from animals injected with EPCs from mice inhaling filtered air. These observations suggest that PM 2.5 inhalation impairs the ability of bone marrow-derived EPCs to promote angiogenesis and skeletal muscle revascularization.
PM 2.5 -Induced Deficits in EPC-Mediated Repair Are Prevented by Pulmonary ecSOD Overexpression
Because pulmonary ecSOD overexpression protected against the CAP-induced changes in EPC tube formation ( Figure 1D ), we next examined whether ecSOD overexpression likewise prevented the PM 2.5 -induced deficit in EPC-mediated vascular repair in vivo. For this, we injected bone marrow-derived EPCs from WT or ecSOD-Tg mice exposed to CAP for 9 days, into unexposed mice subjected to HLI. We found that cells from CAP-exposed ecSOD-Tg mice were significantly more efficient in restoring vascular perfusion than EPCs from their CAP-exposed WT littermates (56.1±3.7% versus 40.3±1.9%; Figure 6A and 6C). Moreover, the extent of recovery was similar to that observed using EPCs isolated from mice breathing filtered air ( Figure 6A and 6C). Isolectin staining was also similar in mice receiving EPCs derived from air-and CAPexposed ecSOD-Tg mice, whereas isolectin staining was decreased by CAP exposure in WT mice ( Figure 6B and 6D) . Taken together, these results suggest that PM 2.5 inhalation generates pulmonary oxidative stress that induces persistent functional defects in bone marrow EPCs impairing their ability to promote vascular repair in vivo.
To gain insight into the mechanisms whereby CAP exposure induces these in vivo functional deficits, we performed a gene array analysis with bone marrow-derived EPCs and quantified the expression of 84 angiogenesis-related genes (Table II in the online-only Data Supplement). We found that 13 genes were downregulated (<0.9 fold) in WT mice exposed to CAP. Interestingly, the expression of a few inflammatory genes (Il-6 and Il-1β) was attenuated, whereas some genes associated with vascular development (Mmp-9, endothelial NO synthase (eNOS), Nos3, and Vegfb) were higher in CAP-exposed ecSOD-Tg mice ( Figure 6E ). For instance, Vegfb levels were elevated in CAP-exposed ecSOD-Tg mice, and whereas CAP exposure decreased Nos3 and Mmp-9 in WT mice, the effects of CAP exposure on Nos3 and Mmp-9 expression were attenuated or absent in ecSOD-Tg mice (Table II in Figure 6F) . Thus, the CAPmediated suppression of Mmp-9 and Nos3 is attenuated in EPCs from ecSOD-Tg mice and thereby may limit the deleterious effects of CAP on EPC function and foster the improved vascular reperfusion we observed after HLI.
Discussion
Although PM 2.5 exposure has been shown to be strongly and robustly associated with an increase in cardiovascular disease risk and mortality, 2,4 the mechanisms by which this pulmonary insult leads to systemic cardiovascular injury remain unclear. The results of the present study, showing defects in angiogenesis, secondary to PM 2.5 -induced pulmonary oxidative stress, reveal a new mechanistic link between PM 2.5 exposure and cardiovascular injury and suggest that functional defects in bone . Pulmonary extracellular superoxide dismutase (ecSOD) overexpression restores the vascular reparative capacity of endothelial progenitor cells (EPCs) after concentrated ambient PM 2.5 (CAP) exposure. Unexposed mice subjected to hindlimb ischemia were injected with bone marrow-derived EPCs from wild-type (WT) and ecSOD-transgenic (Tg) mice inhaling CAP or filtered air for 9 d, and vascular perfusion was assessed after 14 d by laser Doppler perfusion imaging (LDPI). Illustrated are (A) representative LDPI images and percent recovery (C, n=6-10). Also illustrated are (B) microscopic images of isolectin-stained muscle sections collected from the ischemic leg and isolectin fluorescence per mm 2 (D, n=7-10 images). E, The expression of genes coding for angiogenesis-associated proteins (Table II in marrow-derived proangiogenic EPCs may be an important and heretofore unrecognized consequence of PM 2.5 exposure. Our findings demonstrate that PM 2.5 exposure induces multiple, persistent defects in proangiogenic stem cells (eg, a decreased ability to proliferate and form tubes in vitro, decreased abundance in the circulation, and a reduced capacity to stimulate postischemic vascular repair and perfusion recovery in vivo) that together may be significant factors contributing to the cardiovascular morbidity and mortality associated with PM 2.5 exposures. This concept is supported by studies showing that treatments that improve the number and function of EPCs (eg, exercise and antihypertensive drugs) also attenuate cardiovascular dysfunction, 30, 31 and it is consistent with our recent work showing that exposure to episodic increases in PM 2.5 levels in humans is associated with decreased circulating EPC levels and suppressed plasma levels of proangiogenic cytokines and growth factors and an increase in antiangiogenic plasmatic factors. 6, 15 The mechanisms whereby PM 2.5 exposure limits the efficacy of EPCs in promoting in vivo revascularization are likely to be complex. EPCs are thought to promote vascular perfusion either through their terminal differentiation into mature endothelial cells or through paracrine effects on existing cells of the damaged endothelium. 11 Thus, the impaired reparative capacity of EPCs from CAP-exposed mice may simply reflect functional defects, such as in proliferation and tube formation. Similarly, other respirable particulates are reported to affect EPC viability and function. For instance, inhalation of tobacco smoke or nanoparticles has been shown to increase senescence and decrease chemotaxis and tube formation of blood-or bone marrow-derived EPCs of humans or mice. [32] [33] [34] Moreover, direct treatment of cultured human EPCs with diesel exhaust particles impairs their migration, promotes the generation of reactive oxygen species, and triggers apoptosis. 35 Additionally, PM 2.5 exposure may negatively impact the paracrine potential of EPCs by changing the expression or secretion of proangiogenic factors. In support of this idea, we found that CAP exposure attenuates the gene expression of the proangiogenic proteins, MMP-9 (matrix metallopeptidase-9) and eNOS (NOS3), in WT mice. By degrading extracellular matrix, endothelial-secreted MMP-9 supports endothelial invasion and extension of developing vasculature, 36 and indeed, MMP-9-deficient mice display impaired vascular remodeling. 37 The generation of NO by eNOS plays multiple, diverse roles in the regulation of EPC mobilization and function and likewise is essential for new vessel growth. [38] [39] [40] Thus, decrements in these factors may be sufficient to explain EPC dysfunction.
The tube formation, viability, proliferation, and gene expression assays we performed were with cultured cells. Thus, it is not clear whether these results are also reflective of functional changes of EPCs in vivo. Results from a related in vivo study showed that intranasal instillation of diesel exhaust particles impaired neoangiogenesis in apoE −/− mice. 35 However, under those experimental conditions, it is not clear whether the adverse outcomes were mediated through the effects of diesel exhaust particles on EPC function or whether diesel exhaust particles impaired angiogenesis through other mechanism(s). In contrast, our results, showing that injection of EPCs from CAP-exposed animals fail to promote vascular recovery from HLI in unexposed mice ( Figure 5B ), support the idea that PM 2.5 -induced changes in angiogenesis are mediated, in part, by EPC dysfunction. Interestingly, the reduction in vascular repair was similar in animals injected with cells derived from mice exposed to CAP for either 9 or 30 days ( Figure 5B ). Thus, this functional impairment seems to be rapidly induced (≤9 days), saturable and persistent, and has a nonlinear, dose-response relationship. These outcomes are similar to the cardiovascular toxicity associated with cigarette smoking, which is rapid in onset, sensitive and saturable at relatively low levels. 41 Moreover, because PM 2.5 -induced EPC dysfunction persists even after prolonged culture and transplantation (10-26 days), PM 2.5 exposure seems to induce lasting phenotypic changes in these cells. Indeed, PM 2.5 exposure has been shown to induce complex epigenetic changes. 42 Additional investigations are required, however, to determine whether functional defects in EPCs are because of PM 2.5 -induced epigenetic changes in gene expression or whether these are because of long-term changes in cell signaling that modify cell phenotype and function.
Although bone marrow cell dysfunction and its prevention by pulmonary overexpression of ecSOD suggest that the effects of PM 2.5 in the lung manifest in distal tissues and organs, the biochemical and molecular basis of this effect remains unclear. It has been hypothesized that the systemic toxicity of inhaled particles may be because of oxidative stress and the induction of inflammatory responses. 43 This concept is supported by a recent study showing that combined global overexpression of SOD1 (superoxide dismutase 1), SOD3 (superoxide dismutase 3), and glutathione peroxidase prevents the depletion of circulating CD34 + /CD133 + -progenitor cells after intranasal PM instillation. 44 Given the global increase in antioxidant capacity in these mice, however, the specific site wherein oxidative stress is generated could not be identified, and it remains unclear which oxidative events are primarily because of PM 2.5 exposure and which are secondary to the initial reactive oxygen species generation. It has been suggested that biomolecules (eg, lipids) oxidized in the tissue of first contact (lungs) are distributed systemically via the circulation to induce vascular injury. 43 Although there is little direct evidence to support this view, the results presented here provide strong and direct support to the view that oxidative stress local to the lung can be transmitted to circulating cells and to distal tissues, including the bone marrow. This is supported by our observation that PM 2.5 exposure not only impacts the GSH/ GSSG balance in the lungs but also diminishes cellular GSH levels in both circulating and bone marrow EPCs. This depletion because of CAP exposure is prevented in ecSOD-Tg mice. Hence, the results of the present study, in conjunction with our previous findings, 26 suggest that increases in systemic oxidative stress because of inhaled PM 2.5 are linked to pulmonary oxidative stress (eg, superoxide generation) and that inhibition of pulmonary oxidative stress by itself is sufficient to prevent oxidative changes at peripheral sites. A potential limitation of our study is that constitutive ecSOD transgenesis may alter the redox status of circulating and bone marrow-resident EPCs by an unknown mechanism. Moreover, putative biomolecules that are oxidized in the lung and distributed systemically to affect EPC number and function remain to be identified. PM 2.5 -induced pulmonary oxidative stress could arise either through the activation of resident reactive oxygen species-producing cells, such as macrophages, or directly from redox reactions catalyzed and sustained by quinones or redoxactive metals present in PM 2.5 . 45 In humans, redox-active metals in ambient PM 2.5 , such as zinc, nickel, copper, arsenic, and selenium, have been associated with adverse cardiovascular outcomes 46 and lower circulating EPC and plasma VEGF levels. 47 A recent study shows that the induction of oxidative stress contributes to the effects of indoor and outdoor nanoparticles on EPC homeostasis in humans. 48 This study reported that EPC changes were negatively associated with increased reactive oxygen species production in lymphocytes and granulocytes. Furthermore, inhalation of nanoparticles with high nickel content increased various populations of circulating and bone marrow-resident EPCs and impaired tube forming and migratory capacity of bone marrow-derived cells. 34 Thus, particles with high redox potential appear to be more potent in affecting EPC number and function and may be the main contributors to pulmonary oxidative stress because of PM 2.5 inhalation. Because ambient Louisville PM 2.5 is relatively iron-rich, 14 it is likely that metals and also cellular sources (eg, NADPH oxidase) 43 of oxidants trigger pulmonary oxidative stress in our study.
Our previous observations suggest that exposures to volatile components of polluted air, such as acrolein, also reduce circulating EPCs in humans and mice.
49,50 Similar to PM 2.5 , acrolein-induced changes in EPC homeostasis were accompanied by the induction of oxidative stress in circulating EPCs and in the bone marrow. 45, 49 Interestingly, these acrolein-induced effects on EPC levels also seem to result from impaired mobilization because of diminished sensitivity to VEGF. 49 Moreover, we recently demonstrated that both inhaled acrolein and PM 2.5 induce vascular insulin resistance 26, 51 and that treatment with insulin sensitizers not only restored vascular insulin sensitivity but also reversed PM 2.5 -induced EPC depletion. 27 Thus, our current study, together with our previous findings, suggests that both particulate and volatile components of air pollution can impair EPC mobilization by hampering the responses to proangiogenic factors, such as VEGF and insulin. Because ecSOD has been shown to contribute to neovascularization in HLI and to promote VEGF signaling by increasing H 2 O 2 levels, 52 enhanced PM 2.5 -induced H 2 O 2 production in ecSOD-Tg mice may lead to beneficial systemic effects on VEGF signaling, NO production, and VEGF secretion in CAP-exposed ecSOD-Tg mice. This is supported by our data showing increased plasma VEGF levels (Table) , restored vascular VEGF signaling ( Figure 4A ), and increased plasma NO levels ( Figure 4B ) in CAP-exposed ecSOD-Tg mice. These data suggest that changes in the lungs of ecSOD-Tg mice prevent the deleterious effects of CAP exposure on VEGF signaling, NO bioavailability, EPC homeostasis and function as depicted (Graphic Abstract). In addition, our gene array data demonstrated higher expression of Nos3 (eNOS) and Vegfb in bone marrow-derived EPCs from CAP-exposed ecSOD-Tg mice. Further studies are needed to identify the mechanism(s) by which the overexpression of ecSOD in the lungs prevents the CAP-induced changes in the expression or secretion of proangiogenic factors, and how exposure to PM 2.5 impairs vascular signaling responses.
In summary, the findings of the present study demonstrate that PM 2.5 inhalation induces profound defects in angiogenesis after ischemic injury and that these deficits are attributable to pulmonary oxidative stress, which also triggers vascular VEGF resistance and impairs EPC trafficking. Thus, the antioxidant capacity of the lung may be an important determinant of the extent to which PM 2.5 exposure induces cardiovascular injury, and increasing pulmonary antioxidant defenses may attenuate cardiovascular injury induced by exposure to fine particulate air pollution.
